GM12879
melanoma-KO-243
SKmel147
HSC-4
SK-BR-3
IST-MES2
PA1
NCI-H1581
QGP-1
SW 1353
TOV-21G
RC1
COLO-680N
UACC-812
MOLT-3
IOMM-Lee
H6c7
NCI-H2347
T24
H10
Neuron-L2C1
Craig Venter-B (CVB) hiPSC subline
breat cancer cells
Becker
NCI-H1618
hTERT RPE-1
NCI-H1436
melanoma-KO-195
melanoma-KO-24
TUHR4TKB
COLO 741
human KMT2A rearranged MV4;11 AML cell line
MR42D
melanoma-KO-188
PE/CA-PJ34 (clone C12)
HCT 116
Huh7.5
3N1
FGF2 Early Gilteritinib Resistant MOLM14 cells after 48hr Gilteritinib Treatment
SU-DHL-8
NCI-H1573
SNU-423
SCC23
NHU11
EPC
NOMO-1
CMK9
SNU-398
NCI-H1915
Hs 255.T
K7
NCI-H211
OS-RC-2
A3/KAW
PCCB-G1
JEG-3
HEL 92.1.7
SNU-1214
LV-M100 (sublcone of MDA-MB-231)
HeLa cells from ATCC (CCL-2)
OCI-AML2
LNCaP
LCLC-97TM1
KE-39
L02 cells
Hy2-9
CC-2533
OVKATE
HNES1
NCI-H2170
RD-ES
GM12889
CC-2551
MOG-G-CCM
Capan-1
DMS 273
SNU-1041
iMA
HaCaT
DOHH2
melanoma-KO-1
G9_pCDH
TE-1
SNU-119
human iPSC-derived neurons
OCI-C5x single-cell clonal population
human immortalized podocyte (AB8/13)
SK-MEL-24
MKN7
melanoma-KO-20
melanoma-KO-105
TMD8
FTC-133
TE-15
NCI-H1395
melanoma-KO-155
KURAMOCHI
GAMG
melanoma-KO-11
DND-41
92.1
adrenergic
melanoma-KO-109
LNZ308
CC-2555
MOR/CPR
SIHA
melanoma-KO-265
SKNO-1
T47D
Panc1-GR
T29H
SHP-77
hTERT ipNF95.11b C
KOPN-8
OV7
BT12
WERI-RB1
SNU-1196
HeyA8 CD95 k.o. cells clone #11
stem cell
IPSC-L1C2
K562 RNASE1-WT
VCAP
CI0000034840
KYSE-520
EB1
HCC1937
CHLA-C232.2
TS543
LN-319
melanoma-KO-215
SUP-M2
RCC4
VU40T
HepaRGTM cells (HPR 116)
Panc 08.13
PF-382
CEM.NKR.DC-SIGN
1-9-6
MB135
KG-1-C
melanoma-KO-181
K3 Induced pluripotent stem cell
microvascular
PEER
exosome
NCI-H3255
SNU-899
prostate cancer cell line PC3
GDM-1
HDQ-P1
NB-4
H295R
NCI-H1975
n/a
H9; day 2 of differentiation
IPC-298
MCF-7 human breast adenocarcinoma cell line
melanoma-KO-79
Oral squamous carcinoma
SIG-M5
143B
JHOC5
melanoma-KO-159
MEL-HO
KM12
RC1R
PrEC
OCI-LY10
MIA PaCa-2
melanoma-KO-273
T84
H9 ESC line
GCT
SUIT-2
melanoma-KO-276
HCC4006
HDLM-2
KO52
SNU-407
Lis46
melanoma-KO-43
iPSC 7095
melanoma-KO-263
MTB64B
H1299
KU-19-19
PA-TU-8902
SNU-81
HEK 293
BEAS-2B cell line
CC-2565
NCI-H2196
SNU-C5
NCI-H1781
LNCaP/AR
786-O cells
NOS
Hek293
melanoma-KO-80
NCI-H460
melanoma-KO-220
HepG2 hepatocellular carcinoma cell line
SZ-HU-FA
H13
LAMA-84
SW48
JHOM-2B
T-47D
SNU-869
PCCB-G1-NC
UCLA2
UCLA1
HCT-116
GM12887
iPSC
H69
SNU-1066
Hs 739.T
melanoma-KO-230
SHEP parental cells
melanoma-KO-59
HT-144
melanoma-KO-232
JHH-6
OVISE
melanoma-KO-264
1015 (Grayson et al. 2014)
melanoma-KO-99
HEC-59
HA1ER
RERF-LC-MS
451Lu
BRD4 reporter KBM7 cells (REDS15 clone)
Human lens epithelial cell line
Sw480
NCI-H2110
TYK-nu
Raji Burkitt's (B) lymphoma cells (CDK9as)
JK-1
S2
AGS
MCF-7
MFE-280
control1
HUES9 subline
NCI-H508
SNU-1
SH-10-TC
HEK-293T
NIH/3T3
melanoma-KO-250
RT-112
SK-N-FI
KELLY
HKC L2
melanoma-KO-69
KYSE-510
melanoma-KO-93
DU4475
L-363
LUDLU-1
AMO-1
melanoma-KO-166
NCI-H2077;NCI-H1581
melanoma-KO-279
OCI-Ly7
HL60
HT-1080 fibrosarcoma
GSC267
H1975
Jurkat, Clone E6-1 (ATCC TIB-152)
SNU-620
BxPC-3
TM87
CI0000034930
C42-B-Abi
42-MG-BA
CHLA-C275.2
Neuron-L1C2
HBE2
HKC L1
CPC-N
melanoma-KO-67
MRC-5 (ATCC, CCL-171)
SLR 21
COLO-704
NCI-H1339
Hs 706.T
snu719 parental
LN-443
CHLA-ONH348.4
Basal-like triple-negative breast cancer patient-derived xenograft; UCD52
CACO2
Q1007
melanoma-KO-268
S3
SEM
hESCs-CM
MCF7-DoxoR
JM1
TSU-Pr1
melanoma-KO-56
HeLa-229 (ATCC CCL-2.1)
SMS-KCN
A2058
HCC-44
melanoma-KO-15
THP1-derived macrophage
NCI-H1435
COV362
NCI-H2122
BjhTERT
NCI-H1650
COV434
melanoma-KO-72
MHCC-97H
UCLA3
Mino
melanoma-KO-34
SW1116
Set-2
NCI-H660
SNU-216
NCC24
EA.hy926
NALM-19
C2BBe1
NIH-3T3
MV4-11
NCI-H2126
OPM-2
CADO-ES1
S6
AIRE-Tet, Tet-On Advanced HEK293 (Clontech) with inducible AIRE expression
U-937
L3.3
Calu-1
F6
KARPAS-422
Mz-ChA-2
SF268
melanoma-KO-66
OVCAR-8
EOL-1
fetal human cardiac cell line
A375 melanoma cell line
MeWo
melanoma-KO-91
MFE-296
KYO-1
COR-L23
induced neurons
T HESC
melanoma-KO-18
H1 hESC line
ES-2
Panc.05.04
HCC364
MGH28
TTC709
H460
BxPC-5
COLO 684
STK32B
Toledo
RMG-I
ZR75-1
SW403
NCI-H82
A-673
BL-41
A549
GRANTA-519
UCI ADRC76
RUES2
primary cells
H9; day 3 of differentiation
EN
SCC-9
SNU-1197
melanoma-KO-19
melanoma-KO-6
SAS cell
HGC-27
Panc.10.05
melanoma-KO-152
MEC-1
HCC-1438
MPP 89
melanoma-KO-259
NCI-H2172
JJN-3
ACC-MESO-1
THP1
KYSE-30
periodontal ligament cells
LNCaP95
R225X LMNA mutant hiPSCs
CJM
KP-3
F1339
HEC-151
melanoma-KO-223
G-361
missing
HEC-1-A
UI226 SHH Medulloblastoma tumorspheres
HLF-a
melanoma-KO-17
JH-EsoAd1
melanoma-KO-89
melanoma-KO-92
melanoma-KO-163
CH-157MN
NCI-H2085
SNU-761
HMCB
A427
U2OS cell line
COR-L47
Neuron-L1C1
C49R
SKNEP1
HT-1197
#9
CHLA-C275.3
CMK-11-5
HUES6
human foreskin fibroblast cell line HCA2
Du145
IST-MES1
KATOIII
NCI-H1836
Hs 939.T
OZ
PANC-1-GR
Caki-2
SW 900
HUP-T3
Li-7
RKN
OCI-Ly8
melanoma-KO-211
Hs 675.T
Hs 934.T
A101D
KMM-1
UACC-893
TUHR14TKB
A2780 cells subjected to 5 cycles of cisplatin treatment as described (PMID: 9041185).
Hep3B
SNU-349
Panc 04.03
194987
PBMC
RKO
melanoma-KO-50
Co-EVs: mEVs and sEVs were isolated from control vector (pCDNA) expressing MDA-MB231T cells.
RCM-1
SNU-626
639-V
NCI-H2106
SW 780
MDA MB-231
H12
MDA-PCA-2B
L1207
TT
BHT-101
melanoma-KO-21
NCI-H2452
NP460
melanoma-KO-63
UM-UC-3
CCLP1
CT27
SHSY5Y
melanoma-KO-161
SNU-738
CHLA-ONH232.1
NCI-H647
SLR 23
Human astocyte cell line
A2780
MDA-MB-231(HTB-161)
TC-71
TF1 hematopoietic cell line
HCC1428
ABC-1
huh7
TC7 (RRID:CVCL_S881)
melanoma-KO-22
HCC461
OA-MSC2
cutaneous T cell lymphoma cells
melanoma-KO-189
HCC-1588
CSC8
MJ
H1 hESC
Hs 944.T
melanoma-KO-137
Ki-JK
HOP-92
SK-MEL-28
ONCO-DG-1
melanoma-KO-170
H522
HCC2157
AsPC-1
melanoma-KO-172
TGBC14TKB
CA46
769-P
MKN-45
G510NS
Primary fibroblast
HMC-1-8
Human neuroblastoma cell line SH-SY5Y
RS4;11
SNU-213
H1
GM12885
SW1463
TE 617.T
G-401
H8
DAN-G
melanoma-KO-180
A2780 human ovarian cancer cell line
melanoma-KO-145
NCI-H2227
CC-2511
TOV21G
melanoma-KO-242
PTt-P7-MsNL
NSB3188 (iPSC)
NUGC-3
NCI-H226 (CRL-5826)
CHLA-ONH229.3
Hek293-EBNA1-6E ALG6/UGGT12-/-
ES2
Hs 751.T
TE 159.T
EHEB
RC46B
melanoma-KO-85
C3651
YAPC
HSNCC
HFF-1 (ATCC SCRC-1041)
NHDF
melanoma-KO-75
K562 erythroleukemia cell line
NCC19
Human Umbilical Vein Endothelial Cells
S9
melanoma-KO-168
DLBCL cell line LY1
NIH:OVCAR-3
GM12891
CC-2541
melanoma-KO-14
CAL-85-1
CHLA-ONH348.3
melanoma-KO-236
SW 1271
PL-21
melanoma-KO-100
THLE-2
H11
TM-87;TM87
MDA-MB-361
melanoma-KO-245
SW1990
Caov-3
PSN1
IMR-32
SK4
SK-MEL-3
SW620
Sezary Sydrome
IPSC-L1C1
A431
GM09677
IA-LM
Rh30
DMS 153
NCH421k
Hek 293
SKOV3
JHOS-2
ME-1
MCFDCIS
COV318
DEL
NKX2.5:GFP hESCs
TGBC18TKB
A-204
NHEK
NIH3T3
--
BFTC-909
COLO-320
Saos-2
Hs 695T
SKOV3(HTB77)
H9 human neural stem cells
LASCPC01
HCC-2279
melanoma-KO-270
DM-3
CAL-51
HeLa cell lines
melanoma-KO-204
EFM-19
HCC-2108
LNCaP clone FGC
DMS114 small cell lung cancer cell line
HCC-1171
melanoma-KO-140
U87
BeWo
WM-793
MC116
KARPAS-299
Kyse150
U87MG
KhES-3
Malme-3M
NU-DUL-1
GM12882
AGS-EBV
SiHa cell
melanoma-KO-260-262
S7
MC3T3
Human HDMB03 group 3 medulloblastoma cell line
melanoma-KO-31
SW1353
LN-229
RC46B-R
SNU-46
Q1508p1
UCLA4
HeLa (sh FBL integrated)
CMK
LX-2
melanoma-KO-229
bronchial epithelial cell
HCC2450
RH-30
SGC7901
KMRC-1
TKKK
HEC-6
GOS-3
Z138
HSC-1
OV56
melanoma-KO-88
H1 hESCs
MES-SA
Ishikawa
MDA-MB-231 cells
SNU-8
SG231
Human Embryonic Kidney (HEK) 293T-Rex
RERF-LC-Ad1
melanoma-KO-144
T47
Craig Venter-B (CVB) hiPSC line
OUMS-27
JURKAT
VMRC-RCW
SNU-5
PC3 tumor cell line
F121-9 wt mESCs
C4-2
melanoma-KO-226
MDA PCa 2b
SNU-1272
NALM-6
Kasumi-1
RT112/84
UACC-257
MFE-319
BICR 18
HT115
SK-MES-1
YD-8
HT29
SUDHL4
CGTH-W-1
hFM-AEC
SZ-HU-PROB-2
HLF
KYSE-180
A172
GM18502
A-704
EaHy
F12
melanoma-KO-278
SNU-520
WTC-11
HT1376
KNS-42
HCT116 cells
HPAFII
LN-340
HeyA8
LOX IMVI
MTB80
melanoma-KO-114
DB
melanoma-KO-142
JHUEM-7
NY
MHH-CALL-2
NCH601
A549 lung adenocarcinomma cell
PLC-8024
RERF-GC-1B
HCC1599
NCI-H854
YF29
HuH7
MRC-5 cells
NUGC3
KD
HMEC
LEC
SW1417
DK-MG
GP2d
T3M-4
NCI-H596
melanoma-KO-70
U-178
not applicable
melanoma-KO-255
Breast/adenocarcinoma/MDA-MB-231
KG-1a
ZR751
F10
Mia-Paca2
NCI-H196
MG
FULR
Hek293-EBNA1-6E ALG6/UGGT2-/-
PK-45H
SLK
MTB15
Olres-UWB1.289
MDA-MB-231-LM2
MHH-NB-11
KYSE-140
NCI-H2052
KMS-20
NCI-H226
GI-1
H4
NCI-H209
KMS-11
HPAF-II
Hs 936.T
UWB1.289
UM-UC-1
IGR-1
ML-1
CL-40
HPCOA07/03
J82
COLO-699
RPTEC
Kupffer cells (Primary culture (Life technologies))
GM12893
melanoma-KO-156
CASKI
S8
CC-2580
Breast cancer cell line
HCC1500
CHLA-C232.3
melanoma-KO-183
melanoma-KO-61
COLO 201
Molm13
Hs 606.T
Ls174t
MTCHC01
melanoma-KO-37
Hek293-EBNA1-6E ALG6-/-
Hs 888.T
melanoma-KO-251
NCI-H1355
melanoma-KO-267
HeLa S2
1-9
LLC12PH
CAL-62
MSTO-211H
H9
TT2609-C02
IMR90 cells
U937
H3
C8166
F-36P
MKN45
melanoma-KO-210
SCC13
SK-HEP-1
OE21
HCCLM3 cells
HCC-78
melanoma-KO-235
JHUEM-1
melanoma-KO-238
HepG2
OCI-AML5
melanoma-KO-214
U87 glioma cell line
F8
LNCaP-FGC
mESC
SNU-283
hNSC100
MM1-S
SBC-5
melanoma-KO-216
CT1258 (TihoDProAdcarc1258)
ECC10
WM-115
JURL-MK1
GR-M
A-498
LN229
DMS 79
TUHR10TKB
melanoma-KO-73
SNU484
HuT 78
EFE-184
P493
JHOC-5
KOPTK1
NB4
MUTZ-5
T265
SNU-16
SNU-601
melanoma-KO-115
melanoma-KO-47
SK-MEL-5
PTt-P2-MsNL
OUMS-23
Monomac
Hs 852.T
KPL-1
SAS
SNU-1105
BE2N
CI0000035099
CAL 27
BICR 16
HCC515
ALL-SIL
EGFP-DDX6
melanoma-KO-38
TCC-PAN2
SNU-201
EM-2
melanoma-KO-280
NCI-H1930
SW 1573
P3HR-1
melanoma-KO-184
IMR90
HCC-95
TTC1240
YKG1
TC-797 (Toretsky et al. 2003)
NMC-G1
KMS-26
JHOS-4
HUVEC
melanoma-KO-101
HT-1376
melanoma-KO-212
melanoma-KO-119
H9; day 4 of differentiation
Hs 688(A).T
SNU638
NHP cells
melanoma-KO-190
OCI-M1
PTt-P6-MsNL
KCL-22
BxPC-6
BEN
Hs 840.T
MOLM14 Parental cells
melanoma-KO-117
72
GB-1
YCC11
CWR22Rv1 AR-EK
HCC38
HL-60
HLE cells
iPSC-CM
ACCS
HPV 16-immortalized gingival keratinocytes (HIGK)
MON
hFM-AMC
L0615
UT-7
NU-DHL-1
MG63
Caov-4
huh7.5.1
SNU-685
VeroE6
SNU-503
melanoma-KO-57
T98G
SK-OV-3
CC-2902
SUP-HD1
WT hiPSC#2
MPC-11
CSC6
BL-70
SLR 24
differentiated microglia from induced pluripotent stem cells
Hs 746T
LoVo
THP-1
IPSC-L2C2
MonoMac6
H1437
BVSC R8
SNU1967
Panc8
UCLA5
OCI-AML3
SNU620
S10
LS1034
HuNS1
ST486
SW-1710
IGROV1
Lis45
Panc-1
8305C
MCF10A-YAP
HCC2218
78
Hy1-30
NCI-H2444
SJSA-1
LCL1
KMS-28BM
RD ERMS
DOV13
MCF10A
NCI-H1755
BT-483
R225R LMNA corrected 2 hiPSCs
TE-11
HepG2 cells
Kasumi-6
EFO-27
melanoma-KO-136
LK-2
Hs746T
melanoma-KO-36
CC-2538
HCC1395
melanoma-KO-286
melanoma-KO-125
JVM-3
HSC-3
LSPH004 iPSC
NCI-H446
hematopoietic cells
TMZ-resistant U87MG
melanoma-KO-86-116
Thp1
Vero E6 African Green Monkey kidney cell line
BaF3-T315I
22RV1
U2
KNS-81
melanoma-KO-120
Hs 819.T
melanoma-KO-90
SKPNDW
COLO205
melanoma-KO-283
JHH-4
CC-2904
FULVR
CHP-212
HEC1A
BT-549
melanoma-KO-52
melanoma-KO-48
NPC-L1C1
501Mel
NHU12
RUES-2
melanoma-KO-231
PLC/PRF/5
HS360
melanoma-KO-247
RT4
NCC59
AB9
melanoma-KO-122
PC9 U937 mix
PA-TU-8988T
HUES8
LC-1/sq-SF
HD291
SKMES1
NCH644
HCC1806
23132/87
Hep 3B2.1-7
HL60/S4
melanoma-KO-222
MV4;11
L0125
melanoma-KO-253
melanoma-KO-274
SLR 25
G15.AO
NCI-H1651
SW480
Caki-1
SAI5
NCI-H1563
AU565
NCI-H2141
Panc1
OAW28
IGR-37
Hey-A8
293TB4Nf
REC-1
hPSC
X666
M07e cell line
SK-N-DZ
HOS
HELA
CHLA-C229.3
Endothelial cell
CL-34
JEKO-1
HK-2
COLO 668
CAL-148
WM-983B
MCF-10A
melanoma-KO-3
A-375
MDA-MB-453
SMMC-7721
KYSE-70
Caco-2
HAK1A
59M
HEL
N/TERT-2G
MOLM-13
SK-UT-1
TIG-3 TD
NCI-H1650 and NCI-H1975
KGN
melanoma-KO-76
Human umbilical vein endothelial cells
F9
PTt-P8-MsNL
KMS-18
Hs 940.T
D341 Med
LN-235
SNU719
EBC-1
EC-GI-10
NCI-H838
huH-1
NCI-H322
MG-63
C13*
Hek293-EBNA1-6E ALG6/UGGT1-/-
BxPC-4
PCCB-G2
UM-UC-3-pcDNA
KMRC-2
K029AX
T1-73
ZR75
RS-5
HBEC
GSU
RD
SNU-840
WM1799
melanoma-KO-112
HEK293E
KMRC-20
GMS-10
HT
melanoma-KO-285
NCI-H1869
melanoma-KO-234
SZ-HU-MO
none
DV-90
PK-59
AGS, Hs746T, KATOIII, MKN1, MKN28, MKN45, MKN74, NCC19, NCC20, NCC24, NCC59, NCIN87, SK4, SNU1, SNU16, SNU1750, SNU1967, SNU484, NU601, SNU620, SNU638, SNU668, SNU719, YCC11, YCC16, YCC2, YCC3, YCC7
SK-RC-20
AALE cells
786-O
UWB1.289+BRCA1
KMBC-2
F7
CHLA-C275.4
RVH-421
melanoma-KO-186
Hs 839.T
HMLER
HEC-50B
UACC812
MDA-MB-231
GA-10
253J
melanoma-KO-78
Hs 870.T
U266
AALE
HNES3
C42-B
585B1-868
SK-MM-2
NCI-H3122
NCI-H1092
LAPC4
melanoma-KO-51
HEK TE
HCC202
KP-1N
HT22
BT16
Calu-3
melanoma-KO-272
AML-193
HCC-15
SCVI-111
NCI-H526
ZR-75-30
Hs 895.T
SNU-466
SNU-C2A
MEF2C
melanoma-KO-261
Panc 02.03
CL-14
Q1269p1
SNU-C4
C42B
melanoma-KO-121
IPSC-L2C1
201B6 derived ALUBUMIN reporter cell line 12C57
SHP77
OVCAR-5
SK-GT-2
RPMI-7951
DU145 tumor cell line
HEC-1-B
HCC1143
melanoma-KO-81
G401
KYSE-450
SW837
CuFi-1 Cell Line
HCER
FL Early Gilteritinib Resistant MOLM14 cells after 48hr Gilteritinib Treatment
BJAB
SUP-T1
snu-4th highly malignant
melanoma-KO-213
BICR 56
melanoma-KO-175
Wtc11
DOHH-2
Hs 274.T
UCLA6
HCC827 GR5
melanoma-KO-160
ZR-75-1
NCI-H661
SNU-C1
CFPAC-1
MOLT-4
MDCK
MTB15R
M23
KE-97
PTt-P9-MsNL
SKMEL-2
TE-8
SHEP MYCN
HuH-6
HCC1569
CC-2553
H1792
HuH-7
G-402
SNG-M
melanoma-KO-218
C2517A
COLO 829
CHLA-C229.2
KLE
TGBC2TKB
HCC-2814
melanoma-KO-132
UM-UC-3-AR-v19
BV-173
melanoma-KO-111
OVMANA
BICR 6
melanoma-KO-49
231
HBE3
NCI-H1048
DIPG-IV
H9 human embryonic stem cells
melanoma-KO-4
melanoma-KO-103
NCI-H2887
SR-786
NKX2.5eGFP/+-COUP-TFIImCherry/+
HCC2429
MDA-MB-231 lung metastatic cells LM2
LNCAP
CC-2559
SK-ES-1
melanoma-KO-197
Hs 571.T
GCIY
P12-ICHIKAWA
S11
COR-L51
LNCaP-abl (abl)
YH-13
WS1
melanoma-KO-171
CC-7049
NCI-H1838
DBTRG-05MG
LMSU
LN-215
NCI-H1437
MONO-ALLELIC mEGFP-TAGGED TTN WTC iPSC LINE (TAG AT C-TERM)
RCC10RGB
melanoma-KO-153
OV-90
253J-BV
Knee OA dervied chondrocytes
HEK293, HelaS3, and NIH/3T3
Hs 294T
melanoma-KO-64
PC3
OCI-MY7
melanoma-KO-62
RI-1
human mesenchymal stem cells
LN-18
C3649
RT112 urothelial carcinoma cell line
melanoma-KO-5
KMRC-3
A1207
HOP-62
GM12884
KP-N-YN
hFOB1.19
192907
PC10
GM12877
NCI-H2405
IPS
S-117
NCI-H1373
YD-10B
COLO 205
HEK
UMUC9
LS513
MOLT-16
Kasumi1
melanoma-KO-8
BCP-1
647-V
HDMYZ
melanoma-KO-141
GM8330
KYSE-150
MDA-MB-415
SRSF6-GFP
Hy1-25
CAMA-1
NCI-H2171
melanoma-KO-134
iCell Glutaneurons
melanoma-KO-248
N/A
melanoma-KO-185
SUM159
MCF72a-LTED
melanoma-KO-179
SK-LU-1
DKO-1
SK-CO-1
COLO-679
RMUG-S
melanoma-KO-196
melanoma-KO-288
FTC-238
Lis39
S1
CI-1
GSS
NCI-H2073
SNU-410
CC-2561
melanoma-KO-42
primary
MB135 iDUX4
H929
NCI-H1694
NCI-H1944
Mixture of U87 and 67NR
melanoma-KO-35
HUMEC
CALU6
PANC-1
SNU1
melanoma-KO-39
HEC-251
melanoma-KO-27
EFM-192A
KATO III
NC3
COLO-800
melanoma-KO-74
HMEC-1
Huh7
SNU-1033
PTt-P1-MsNL
GM12890
BJ
melanoma-KO-217
UO-31
OC 314
U-138 MG
KNS-60
5637
MB135-DUX4
melanoma-KO-228
melanoma-KO-97
melanoma-KO-173
SLR 20
NCI-H146
OPM-1
melanoma-KO-139
SKBR3
Daoy
SiHa
melanoma-KO-281
MTB80R
melanoma-KO-108
KYSE-270
MTB107-R
HSC-2
KMS-27
MGC803 cells
LNCaP tumor cell line
NCI-H1341
D10
JMSU-1
SNU-175
melanoma-KO-167
HCC-1359
melanoma-KO-82
Hs 742.T
melanoma-KO-16
CC-2556
SCVI-111 TBX5-Lineage Reporter Line
melanoma-KO-198
NCI-H441
melanoma-KO-32
KU812
HAP1
MTB67-R
melanoma-KO-10
melanoma-KO-221-233
Pfeiffer
melanoma-KO-128
SUP-B15
PCCB-G2-NC
melanoma-KO-194
WSU-DLCL2
HD-MY-Z
BT89
WT Hek293-EBNA1-6E
ST88-14
GES-1
melanoma-KO-106
OAW42
CC-2587
H226
GM12878
JHH-5
KP-N-RT-BM-1
SZ-HU-PROB
BICR 31
D149 NSC
melanoma-KO-239
melanoma-KO-240
Hs 698.T
MOTN-1
Hs 172.T
NCI-H889
585A1
melanoma-KO-143
TF-1
SH-SY5Y
NCO2
NCI-H1105
reticulocytes
Calu3
YCC3
NUGC-4
Loucy
SMS-CTR
SCC-4
SCC-9 cells
GM12888
melanoma-KO-154
Hs 834.T
NUGC-2
NCI-H28
melanoma-KO-275
DU 145
YD-38
TO 175.T
melanoma-KO-266
RERF-LC-KJ
OVCAR8
F5
HCC-366
NCI-H929
Hs 343.T
melanoma-KO-205
FLT3-ITD+ AML cell lines (MV4-11)
FU97
LS411N
COLO 775
WA01 (H1 ES)
melanoma-KO-60
192627
SU-DHL-5
SKM-1
SNU-61
NCC20
melanoma-KO-157
MDA-MB-134-VI
LX2
VMRC-LCD
HCT-15
MDA MB-436
HARA
H5
EB2
HCCLM3
KASUMI-2
melanoma-KO-53
KARPAS-620
melanoma-KO-26
A-253
OVCAR3 (HTB161)
CC-2550
SNU-475
NCI-H1793
SZ-HU-MO-2
melanoma-KO-94
MHH-ES-1
NCI-H1876
SNU-449
NCI-H716
#8
VMRC-RCZ
HCC1419
BC-3C
LS123
HuCCT1
LAD2 Mast Cell
teloHAEC
KP-2
MV411
A4/Fuk
HCB1
NCI-H2228
MEG-01
melanoma-KO-129
Reh
ADR
SK-MEL-147
BT474
melanoma-KO-187
melanoma-KO-224
NCI-H810
SK-N-SH
H9 hESC
P31/FUJ
SNU-878
SW948
NCI-H684
TEN
HAP1 cells
U343
MDA-MB-468
Hep G2
FOB
H460 cell line
BOFS hiPSC cl2
SU-DHL-10
melanoma-KO-202
HRMEC
HCC2935
CC-2508
SH-EP (MYCN overexpressing)
A2780cis
MGH26
NME2_EVs: mEVs and sEVs were isolated from MYC::NME2 overexpressing MDA-MB231T cells.
TPC-1
Hela
melanoma-KO-191
Detroit 562
U-251 MG
LP-1
RPMI-8402
melanoma-KO-77
HH
MET4
melanoma-KO-54
SCC12
BDCM
G402
MTB64B-R
SK-LMS-1
RPMI 8226
STM9101
MV-4-11
NAMALWA
SNU1750
NCI-H1963
MOLM-16
melanoma-KO-65
MM.1S
SW 1088
SJRH30
melanoma-KO-176
n.a.
melanoma-KO-271
UO9
CL-11
NCI-H2342
melanoma-KO-46
SIMA
SCC-25
CHLA-C232.1
HCT116
BICR 22
SCLC-21H
CC-2554
COLO-783
MCF7-derived LY2
SCC-15
PE/CA-PJ49
MEL-JUSO
KHM-1B
NCI-H2029
DU145
MMC70
NOK
Hs 729
OCUM-1
MKN1
NA
NCI-H2286
melanoma-KO-269
Ovcar8
TTC642
CML-T1
SU-DHL-1
MOLT-13
U-BLC1
CAS-1
melanoma-KO-110
Panc 05.04
SNU-308
melanoma-KO-55
HCC1954
NCI-H747
PARCB
OVSAHO
DMS 454
UOK101
CRL-4003
BEAS-2B
melanoma-KO-193
melanoma-KO-148
HMEL
UPN2
Latently infected N6 clone of Jurkat cell line
Panc 02.13
NCI-H1385
R225R LMNA corrected 1 hiPSCs
SF539
HeLa
HEC-265
293T
RH-41
CW-2
NCI-H1693
HEK293
MIFF3
NCI-H1734
NCI-H727
C3647
U2OS pTRIPZ-YFP-ER-E2F1
melanoma-KO-87
COR-L95
MGH31
melanoma-KO-58
PC3M
Human hair follicle dermal papilla cell (HFDPC)
MHH-CALL-4
NCIH2882
MiaPaCa
SNU-668
RCH-ACV
HCC70
SNU16
BE-(2)-C
melanoma-KO-102
COLO-818
PCM6
KALS-1
COV644
Hs 611.T
melanoma-KO-124
CCK-81
SCaBER
KYSE150
SH-EP (Venus-overexpressing)
ADSC
SNU-182
HEMn-LP
melanoma-KO-41
NOMO1
LN-464
melanoma-KO-164
COLO-678
SK-N-AS
HBE4
RERF-LC-Ad2
melanoma-KO-209
SU-DHL-6
NCI-H69
PLB-985
TE-6
K562
BHY
HEK 293T
melanoma-KO-30
Panc 03.27
SNB19
MiaPaCa2
TTC549
HCET
H2
YCC2
MOLM13
IGR-39
Kg1a
Huh7 cells
HTK-
Embryonic kidney cell line HEK293T
melanoma-KO-138
GM21
OCUM1
SJ
SK-N-MC
NCI-H2030
Hs 616.T
U-87 MG
vorinostat-resistant HCT116
NCI-H1299
MB135 parental
DMS 53
SNU-478
HK2
HPB-ALL
TE-5
BFTC-905
OVK18
MOLP-2
L-540
SUP-T11
DKs-8
melanoma-KO-244
ES03
melanoma-KO-95
IMR90 human primary lung fetal fibroblasts
OVCAR4
KASUMI-1
melanoma-KO-9
melanoma-KO-146
WI-38
MDST8
HeLaXBP1s cells
OVTOKO
RL
KMS-21BM
HNES2
Capan-2
JAR
HT-29
AN3 CA
NCI-H1568
MDA-MB-436
SNU-245
NCI-H2087
H157
BLaER1
SNU668
THP-1 cell line
OCUG-1
melanoma-KO-13
FaDu
KP-1NL
melanoma-KO-130
SK-MEL-2
PC-3
LS174T
PGP1 cell line, Coriell Institute, male
NCI-N87
GM12892
OELE
HuTu 80
Hs 766T
CAL-120
SLR 26
BE(2)-m17 (ATCC CRL-2267)
ESS-1
SK-MEL-31
CC-2586
GM12880
derived from Ramos
SF8657
melanoma-KO-177
1-7
HCC1187
TAMR
VMRC-LCP
F11
mesenchymal
HT55
SW 1990
melanoma-KO-7
M-07e
CCF-STTG1
COR-L279
Lis38
RT112
PDX#3 (in house)
Hs 821.T
MDA-MB-157
HK1
HRT-18
F3
SUM1315
melanoma-KO-182
melanoma-KO-45
M059K
NCI-H841
ChaGo-K-1
RH-18
HCT15
MOLM-6
melanoma-KO-249
PrEC LH
F2
melanoma-KO-287
melanoma-KO-12
107CRC
ECC12
CD133+ D456MG
melanoma-KO-192
KYSE-410
SW579
MUTZ-3
TALL-1
HeLa CRISPR/Cas9 clone E7
MDA-MB-330
hTERT-RPE1
SK-MEL-30
JIMT-1
WM-88
JHH-1
DND41
KMS-34
Hs 281.T
SNU-886
NuLi-1 Cell Line
SK-N-BE(2)
BOFS hiPSC cl3
JHH-2
SNU-719
JHUEM-2
SZ95 sebocytes
naive induced pluripotent stem cells
melanoma-KO-158
H596
OCI-LY-19
TE 125.T
SNB75
CAL-78
WA01 TH #2 HESC
SNU-1040
MOG-G-UVW
COV504
hFM-DEC
NCI-H1792
OVCA433 cells
melanoma-KO-113
SK-MEL-1
HuT 102
MB468
TE 441.T
8-MG-BA
N87
KYM-1
H1 hESC cell line
NCI-H1666
Granta-519
KP-N-SI9s
OCI-Ly1
melanoma-KO-256
HAK1B
TE-9
EFO-21
NCI-H1155
SF126
LN-428
HCT116oxR
A375/211 melanoma cell line
Q1508
AM-38
gastric carcinoma cell line SNU-719
PC9
EKVX
RERF-LC-Sq1
CAL-33
LXF-289
Hs 683
hFM-CTC
BRD4 reporter KBM7 cells (REDS1 clone)
melanoma-KO-257
HCC-56
Human MB3W1 group 3 medulloblastoma cell line
LC-1F
SW 1783
U-118 MG
TGBC11TKB
L-1236
UACC-62
Akata
HeLa cell line
SW13
NCI-H510
melanoma-KO-241
Jurkat T-lymphocytes
SNU-324
ACHN
Kyse30
HCC-33
U251
Chap
MCF7 cells
HeLa cells
LN382
BM2222
MOLP-8
SF767
melanoma-KO-277
SALE
JL-1
G-292, clone A141B1
LU99
NCI-H2066
MONO-MAC-6
Hct116
NCI-H2023
C3A
TC28a2
OE33
alveolar epithelial cell
Hs 578T
BT-12
CC-2509
CHLA-ONH232.3
melanoma-KO-126
melanoma-KO-201
PTt-P3-MsNL
107CRCR
NCI-H524
JeKo-1
SNU-489
melanoma-KO-29
LOU-NH91
OE19
U266B1
CUTLL1
PERI
melanoma-KO-147
Hs 737.T
RPMI 6666
JVM-2
A375
D149 iPSC
OVCAR-4
H3122
G2
CTR M3 36S
CHP-126
melanoma-KO-206
SA
NCI-H2004 RT
melanoma-KO-98
L-428
KPMRTRY
WIBR3dPE hESC
HCC1806RR
SF-295
MTB67
melanoma-KO-165
prostate cancer cell line LNCaP
HCC-1833
D283 Med
TM-31
BT-20
B-CPAP
SU-DHL-4
Olres-UWB1.289+BRCA1
prostate cancer cell line C42B
Moml13
CC-2527
MTB107
Hep2
UMUC3
HUCCT1
TE-4
Hs 618.T
EVSA-T
melanoma-KO-33
Kuramochi
EPLC-272H
MRC5
NCI-H520
TIGK
G415
melanoma-KO-246
PE/CA-PJ41 (clone D2)
melanoma-KO-254
F1
SNU-387
TE-10
melanoma-KO-83
RC9-AB230
JHOM-1
LU65
NCI-H358
ONS-76
NPC-L2C1
Hs 600.T
HDF
NCI-H650
melanoma-KO-282
NPC-L2C2
Q1039
CHL-1
CAL-12T
KE-37
BEAS2B
PE/CA-PJ15
CC-7014
nCSC
Hy1-29
PA-TU-8988S
CC-2931
melanoma-KO-23
melanoma-KO-219
IM95
melanoma-KO-68
KNS-62
COR-L311
Hs 604.T
OC 316
SCH
SU.86.86
NOZ
C70R
GM12881
NALM6
melanoma-KO-208
DAOY
OCI-C5x
melanoma-KO-84
HEK293T
C32
NCIN87
Panc 10.05
melanoma-KO-107
BxPC-8
GOT1
MEC1
NCI-H2081
HCC-LM3
Raji
PTt-P4-MsNL
NCC-StC-K140
LOVO
Daudi
LAPC9
HNT-34
Molm-14
HuG1-N
MDA-MB-435S
BOFS hiPSC cl1
Hs 822.T
MDA-MB231 cells
TE-14
OCI-LY3
PK-1
human embryonic kidney cell line HEK 293T
melanoma-KO-151
NCI-H1819
SBC-3
Y79
MDA MB-361
F4
MHH-CALL-3
KP4
LK2
NPC-L1C2
CACO2;CACO2;CaCo-2
MP107
KMS-12-BM
22Rv1
SCLI
HEK293T and 3T3
NCI-H2009
melanoma-KO-162
T3M-10
S4
NCI-H292
NHBE
BT67
NH-6
melanoma-KO-44
COLO 792
melanoma-KO-127
Hermes 3A
YD-15
melanoma-KO-28
melanoma-KO-133
NCI-H1623
SF-172
DMS 114
SNU216
KG-1
COR-L105
MM1S
melanoma-KO-123
KM-H2
SNU-1076
Tri-DS3
DLD-1
TFK-1
melanoma-KO-169
NCI-H2291
K562 RNASE1-mutant
JHUEM-3
HPAC
MET1
SUM149PT cells
TOV-112D
Ishikawa (Heraklio) 02 ER-
RL95-2
melanoma-KO-252
melanoma-KO-118
MOLT4
SNU-1077
NCI-H1703
CAL-54
COR-L88
H9 Embryonic stem cell
NCI-H1648
HCjE
melanoma-KO-284
U2OS
TCCSUP
iSLK.219
WM902B
Hs 863.T
MKN74
NHC3
EW8
INA-6
HEPG2
MCF-7 human breast cancer cells
NB-1
JHH-7
RERF-LC-AI
Neuron-L2C2
MP107R
AMC-HN-8
TC32
melanoma-KO-2
OCIMY5
Calu-6
Di-DS3
U-2 OS
NME1-EVs: mEVs and sEVs were isolated from FLAG::NME1 overexpressing MDA-MB231T cells.
melanoma-KO-104
BJ Fibroblast
MONO-MAC-1
MCF7
VM-CUB1
melanoma-KO-25
Fibroblast-1
SH-4
Jurkat T cell
CAL-29
NALM-1
H6
HeLa CRISPR/Cas9 clone B13
KS-1
VCaP
WM-266-4
melanoma-KO-40
Hs 229.T
NCI-H522
GM12883
NCI-H1184
melanoma-KO-203
SMS-KCNR
HT-1080
PCCB-G2-3
melanoma-KO-131
melanoma-KO-227
CCD-18Co
NKYS
1-7-24
LCLC-103H
MKN28
1-7-5
HUP-T4
76NF2V
SNU-1079
HCC827
FU-OV-1
Hy2-16
NHAHTDD
GL261fluc
HuH28
Sk-ChA-1
melanoma-KO-200
COR-L24
EGI-1
H9; day 1 of differentiation
K-562
PC-14
HEC-108
501MEL
697
EJM
S5
LS 180
8505C
BT-474
MCAS
RPMI-8226
C4-2B prostate cancer
EWS502
MDA-MB-175-VII
HCC-1195
NCI-H23
